AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can cause liver injury and even liver failure. INH metabolism has been thought to be associated with INH-induced liver injury. This review summarized the metabolic pathways of INH and discussed their associations with INH-induced liver injury
Isoniazid (INH), one of the most effective agents in the treatment and prophylaxis of tuberculosis a...
Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tu...
Data of a comparative assessment of procedures for isoniazid phenotyping and acetylation as well as ...
AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can caus...
Isoniazid (INH) is a synthetic anti-mycobacterial agent used to treat active or latent tuberculosis ...
Isoniazid (INH or isonicotinic hydrazide) is used for the treatment and prophylaxis of tuberculosis....
Isoniazid (INH or isonicotinic hydrazide) is used for the treatment and prophylaxis of tuberculosis....
The prevalence of latent tuberculosis infection (LTBI) in the United States in 2011 and 2012 was est...
Hepatotoxicity is the main concern during tuberculosis chemotherapy with the first-line drugs isonia...
Antituberculosis drug-induced hepatotoxicity (ATDH) complicates the treatment of 5-10% of patients t...
Approximately one-third of the world's population harbors the tuberculosis mycobacterium and it is ...
This paper describes a case of an acute and fatal isoniazid-induced hepatotoxicity and provides a re...
Background: Tuberculosis is the public health disease of Pakistan. Liver is the site of metabolism f...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
The cornerstone of tuberculosis management is a 6-month course of isoniazid, rifampicin, pyrazinamid...
Isoniazid (INH), one of the most effective agents in the treatment and prophylaxis of tuberculosis a...
Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tu...
Data of a comparative assessment of procedures for isoniazid phenotyping and acetylation as well as ...
AbstractIsoniazid (INH) is highly effective for the management of tuberculosis. However, it can caus...
Isoniazid (INH) is a synthetic anti-mycobacterial agent used to treat active or latent tuberculosis ...
Isoniazid (INH or isonicotinic hydrazide) is used for the treatment and prophylaxis of tuberculosis....
Isoniazid (INH or isonicotinic hydrazide) is used for the treatment and prophylaxis of tuberculosis....
The prevalence of latent tuberculosis infection (LTBI) in the United States in 2011 and 2012 was est...
Hepatotoxicity is the main concern during tuberculosis chemotherapy with the first-line drugs isonia...
Antituberculosis drug-induced hepatotoxicity (ATDH) complicates the treatment of 5-10% of patients t...
Approximately one-third of the world's population harbors the tuberculosis mycobacterium and it is ...
This paper describes a case of an acute and fatal isoniazid-induced hepatotoxicity and provides a re...
Background: Tuberculosis is the public health disease of Pakistan. Liver is the site of metabolism f...
Tuberculosis (TB) is a chronic bacterial infection caused by Mycobacterium tuberculosis complex, mos...
The cornerstone of tuberculosis management is a 6-month course of isoniazid, rifampicin, pyrazinamid...
Isoniazid (INH), one of the most effective agents in the treatment and prophylaxis of tuberculosis a...
Isoniazid (INH) monotherapy has gained widespread acceptance as an efficacious therapy for latent tu...
Data of a comparative assessment of procedures for isoniazid phenotyping and acetylation as well as ...